Scholarlink

<p>One of the major causative genes involved in Frontotemporal dementia (FTD) is <i>Granulin</i> (<i>GRN)</i>, encoding for Progranulin (PGRN). <i>GRN</i> mutation carriers show a substantial heterogeneity with high variability in age at onset and pathological presentation, even within the same family or identical mutations, suggesting the presence of additional genetic factors. Single nucleotide polymorphisms in the Transmembrane protein 106B (<i>TMEM106B)</i> locus were identified as a genetic risk-associated factor for FTD. The top variant identified was the non-coding <i>rs1990622</i>, with the major allele (T) associated with an increased risk to develop FTD, while subjects with the minor allele (C) were less likely to develop disease, suggesting a protective effect. In this study, we investigate in a large Italian cohort of <i>GRN</i> mutation carriers, how the coding variant <i>TMEM106B</i>-<i>rs3173615</i>, in linkage disequilibrium with <i>rs1990622</i>, modulates age at onset, survival, and PGRN levels, including, up to date, the highest sample size of homozygous protective allele carriers. Genetic screening for <i>TMEM106B-rs3173615</i> was performed on a total of 187 <i>GRN</i> mutation carriers, comprising 131 FTD patients and 56 pre-symptomatic subjects. Individuals with the protective genotype (GG) had a risk of FTD onset reduced by 80%, with a median age at onset of 77 years compared to a median age at onset of 63 years for individuals without the protective genotype. <i>TMEM106B-rs3173615</i> acts as a genetic modifier of age at onset in the presence of <i>GRN</i> mutations and could be considered in clinical practice to optimize risk stratification for FTD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protective TMEM106B-rs3173615 delays age at onset in GRN mutation carriers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月18日

查看全文
  • Lorenzo Pagano,
  • Claudia Saraceno,
  • Andrea Geviti,
  • Silvia Fostinelli,
  • Alessandro Facconi,
  • Valentina Laganà,
  • Giulia Giacomucci,
  • Maria Sofia Cotelli,
  • Assunta Ingannato,
  • Silvia Bagnoli,
  • Antonio Longobardi,
  • Alice Russotto,
  • Sonia Bellini,
  • Davide Lagrotteria,
  • Ersilia Paparazzo,
  • Giuliano Binetti,
  • Alberto Montesanto,
  • Benedetta Nacmias,
  • Raffaele Maletta,
  • Barbara Borroni,
  • Roberta Ghidoni

摘要

One of the major causative genes involved in Frontotemporal dementia (FTD) is Granulin (GRN), encoding for Progranulin (PGRN). GRN mutation carriers show a substantial heterogeneity with high variability in age at onset and pathological presentation, even within the same family or identical mutations, suggesting the presence of additional genetic factors. Single nucleotide polymorphisms in the Transmembrane protein 106B (TMEM106B) locus were identified as a genetic risk-associated factor for FTD. The top variant identified was the non-coding rs1990622, with the major allele (T) associated with an increased risk to develop FTD, while subjects with the minor allele (C) were less likely to develop disease, suggesting a protective effect. In this study, we investigate in a large Italian cohort of GRN mutation carriers, how the coding variant TMEM106B-rs3173615, in linkage disequilibrium with rs1990622, modulates age at onset, survival, and PGRN levels, including, up to date, the highest sample size of homozygous protective allele carriers. Genetic screening for TMEM106B-rs3173615 was performed on a total of 187 GRN mutation carriers, comprising 131 FTD patients and 56 pre-symptomatic subjects. Individuals with the protective genotype (GG) had a risk of FTD onset reduced by 80%, with a median age at onset of 77 years compared to a median age at onset of 63 years for individuals without the protective genotype. TMEM106B-rs3173615 acts as a genetic modifier of age at onset in the presence of GRN mutations and could be considered in clinical practice to optimize risk stratification for FTD.